Epizyme, Inc.
INHIBITORS OF EZH2 AND METHODS OF USE THEREOF
Last updated:
Abstract:
The disclosure provides a method of treating cancer in a subject in need thereof including administering to the subject a therapeutically-effective amount of an enhancer of a zeste homolog 2 (EZH2) inhibitor. In certain embodiments of this method, the subject has one or more mutations in one or more sequences encoding a gene listed in Tables 1-9, Tables 17-19, and/or FIGS. 19-22.
Status:
Application
Type:
Utility
Filling date:
9 Dec 2021
Issue date:
23 Jun 2022